Lion Point Capital, LP ARQT — ARCUTIS BIOTHERAPEUTICS INC

Ownership history in Lion Point Capital, LP  ·  6 quarters on record

AI Ownership Summary

Lion Point Capital, LP reported ARCUTIS BIOTHERAPEUTICS INC (ARQT) in 6 quarterly 13F filings from 2024 Q3 through 2025 Q4. Peak portfolio weight reached 4.62% in 2025 Q1. The latest visible filing shows ARQT at 0.79% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this ARQT ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Lion Point Capital, LP's position in ARCUTIS BIOTHERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

ARQT was reported at 0.79% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
4.62% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

ARQT stock page Lion Point Capital, LP fund profile Lion Point Capital, LP full holdings
How Lion Point Capital, LP held ARQT — position size vs. price
% of Fund (quarterly)    ARQT price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 6 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 85.1% -18.9% ✅ 5,250 -30,050 -85.1% 0.79% $152K 2026-02-14 (Est.) $25.86
2025 Q3 REDUCED 23.8% +51.5% ❌ 35,300 -11,000 -23.8% 3.78% $665K 2025-11-14 $25.00
2025 Q2 UNCHANGED — — — 46,300 — 0% 4.41% $649K 2025-08-14 $15.98
2025 Q1 UNCHANGED — — — 46,300 — 0% 4.62% $724K 2025-05-15 $13.63
2024 Q4 ADDED — — — 46,300 +11,200 +31.9% 3.38% $645K 2025-02-14 $12.78
2024 Q3 INITIATED — — — 35,100 — — 0.73% $326K 2024-11-14 $9.93

🏢 Other funds also holding ARQT

As of 2026 Q1 — sorted by position size

FISHMAN JAY A LTD/MI 3Y 7Y 1.19% 1492 Capital Management LLC 3Y 7Y 1.06% Perpetual Ltd 3Y 7Y 0.33% PSP Research LLC 0.33% PEREGRINE CAPITAL MANAGEMENT LLC 3Y 7Y 0.27% MFA Wealth Services 0.25% ZEVENBERGEN CAPITAL INVESTMENTS LLC 3Y 7Y 0.24% Phocas Financial Corp. 3Y 7Y 0.19% Candriam S.C.A. 3Y 7Y 0.13% KORNITZER CAPITAL MANAGEMENT INC /KS 3Y 7Y 0.09%

FAQ About Lion Point Capital, LP and ARQT

These are the practical questions this page is built to answer before you even open the full history table.

How long has Lion Point Capital, LP reported owning ARQT?

Lion Point Capital, LP reported ARQT across 6 quarterly 13F filings, from 2024 Q3 through 2025 Q4.

What was the largest reported ARQT position in Lion Point Capital, LP's portfolio?

The largest reported portfolio weight for ARQT was 4.62% in 2025 Q1.

What is the latest reported ARQT position on this page?

The most recent filing on this page is 2025 Q4, when Lion Point Capital, LP reported 5,250 shares, equal to 0.79% of portfolio, with an estimated market value of $152K.

What does the chart on this ARQT ownership page compare?

The chart compares Lion Point Capital, LP's quarterly ARQT portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Lion Point Capital, LP time their ARQT position?

Based on 13F filing dates vs. subsequent ARQT price moves, Lion Point Capital, LP correctly timed 2 out of 3 reported position changes (67%). The annualised alpha on ARQT relative to SPY over the holding period was +90.0%.

← Back to Lion Point Capital, LP Holdings